Showing posts with label prostate. Show all posts
Showing posts with label prostate. Show all posts

Monday, 28 August 2023

Current Trend in the Cancer Symptoms | Chapter 8 | Current Progress in Medicine and Medical Research Vol. 9

This Chapter chiefly focuses on Cancer related manifestations in the diagnosed case and non distinguishing symptoms of tumor and also in the non curable malignancy Patient.  It also shows the appearance of such syndromes in the pre and post Chemotherapy, Radiation therapy and in Surgical Intervention for the inmates undergoing Cancer Treatment.Cancer being the 2nd chief cause of mortality in the experience is a major public concern can influence any part of the crowd. Breast cancer in the women and prostrate cancer in the men are most commonly happening form of the Cancer. As it is diagnosed late in the underdeveloped countries higher rates of allure occurrence are found.Cancer accompanying symptoms like Anxiety, despair, psychological disorders, sleep disorder, fatigue, pain and working impairment. Cancer sufferers suffer from extreme burden of these symptoms that could happen as complications, initially following in position or time therapy or all along long term healing may last from months to age. This leads to feeling of incompetence and hopelessness that can seriously influence the quality of life.

Author(s) Details:

Noel Samuel Macwan,
College of Physiotherapy, Sumandeep Vidyapeeth, Piparia, Waghodia, Vadodara, Gujarat, 391760, India.

Please see the link here: https://stm.bookpi.org/CPMMR-V9/article/view/11692

Friday, 28 July 2023

Determination of Sarcomatoid Carcinoma of the Prostate with Bladder Invasion: About Two Case Reports | Chapter 10 | Current Progress in Medicine and Medical Research Vol. 5

 This branch report two cases of prostate SC with bladder attack not long following in position or time transurethral resection of the prostate (TURP) and androgen deprivation.  In order to concisely summarise the biochemical, morphological, and image features of sarcomatoid cancer (SC) of the prostate accompanying bladder encroachment shortly after emasculation.Our two cases were initially determined with adenocarcinoma of the prostate due to dysuria. However, prostate SC was pronounced after transurethral redistribute of the prostate (TURP) and castration after only 5 and 10 mo, individually. Distinctive liver-like tissues appeared in the second TURP procedure as long as 1, while a white, bob flesh-like, narrow pedicled soft sphere protruded from the prostate to the pouch in case 2. Our study results suggest that SCs grant permission originate from a distinguished group of hormonal resistant prostate stromal cancer containers found familiar the bladder neck and they grant permission accelerate their growth when unprotected to stimulation and changes in their atmosphere.One of the unique cancer container populations that are opposing to hormone therapy concede possibility be where the sarcomatoid component of SC cultivates. SCs' morphological traits can manifest as "chum flesh" and "wine hepatization". SCs grow rapidly and have a poor prognosis, and accordingly, extensive TURP plus fallout may be the treatment of choice.

Author(s) Details:

Wei Wei,

Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Qi-Guang Li,

Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Xian Long,

Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Gao-Hua Hu,

Department of Thyroid and Breast Surgery, Qichun People’s Hospital, Qichun 435300, Hubei Province, China.

Hua-Jie He,

Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Yuan-Bi Huang,

Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Xian-Lin Yi,

Department of Urology, Cancer Hospital of Guangxi Medical University & Guangxi Cancer Research Institute, No. 71 Hedi Road, Nanning 530021, China and Department of Urology, Wuming Hospital of Guangxi Medical University, No. 26 YongNing Road, Nanning 530199, Guangxi Zhuang Autonomous Region, China.

Please see the link here: https://stm.bookpi.org/CPMMR-V5/article/view/11390